Kyle Greenway
Lab Director
Dr. Greenway’s work focuses on non-idealised psychiatric patients, investigating how extra-pharmacological factors influence both psychedelic and conventional therapies. His research develops novel treatment protocols while exploring how interventions can be tailored to individual patients based on their unique life experiences and cultural contexts.